Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway.
S. Moreau‐Marquis,
B. Stanton,
G. O’Toole
|
8 |
2008 |
8
2008
|
Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review.
A. Sadowska,
B. Manuel-y-Keenoy,
W. D. Backer
|
8 |
2007 |
8
2007
|
The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
8 auth.
A. Hatzelmann,
E. Morcillo,
G. Lungarella,
S. Adnot,
S. Sanjar,
R. Beume,
...
C. Schudt,
H. Tenor
|
8 |
2010 |
8
2010
|
Reactive oxygen species as mediators in asthma.
P. Henricks,
F. P. Nijkamp
|
8 |
2001 |
8
2001
|
The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.
M. Cazzola,
M. Molimard
|
7 |
2010 |
7
2010
|
Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes.
U. Juergens,
Tanja Engelen,
K. Racké,
M. Stöber,
A. Gillissen,
H. Vetter
|
7 |
2004 |
7
2004
|
Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view.
9 auth.
S. Saturni,
Federico Bellini,
F. Braido,
P. Paggiaro,
A. Sanduzzi,
N. Scichilone,
...
P. Santus,
L. Morandi,
A. Papi
|
7 |
2014 |
7
2014
|
cAMP regulation of airway smooth muscle function.
C. Billington,
O. Ojo,
R. Penn,
S. Ito
|
7 |
2013 |
7
2013
|
The Non-neuronal cholinergic system: an emerging drug target in the airways.
I. Wessler,
C. Kirkpatrick
|
7 |
2001 |
7
2001
|
Lung cancer in patients with idiopathic pulmonary fibrosis.
8 auth.
T. Karampitsakos,
V. Tzilas,
R. Tringidou,
P. Steiropoulos,
V. Aidinis,
S. Papiris,
...
D. Bouros,
A. Tzouvelekis
|
7 |
2017 |
7
2017
|
Resolvin D1 protects mice from LPS-induced acute lung injury.
7 auth.
Bin Wang,
X. Gong,
J. Wan,
Li Zhang,
Zhuo Zhang,
Hong-zhong Li,
...
S. Min
|
7 |
2011 |
7
2011
|
Clinical application of forced oscillation.
Michael D. Goldman
|
7 |
2001 |
7
2001
|
Glucocorticoid-regulated transcription factors.
I. M. Adcock
|
7 |
2001 |
7
2001
|
The inhalers of the future? A review of dry powder devices on the market today.
I. J. Smith,
M. Parry-billings
|
7 |
2003 |
7
2003
|
Molecular mechanisms of glucocorticosteroid actions.
I. Adcock
|
7 |
2000 |
7
2000
|
